US Patent 10980784 Rapamycin analogs and uses thereof
Patent 10980784 was granted and assigned to Navitor Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+109 characters)
Article
Patent abstract
The present invention provides compounds, compositions thereof, and methods of using the same.
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109807840
Date of Patent
April 20, 2021
0Patent Application Number
164432980
Date Filed
June 17, 2019
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109807840
Date of Patent
April 20, 2021
0Patent Application Number
164432980
Date Filed
June 17, 2019
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10980784 Rapamycin analogs and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10980784
Date of patent
April 20, 2021
Patent application number
16443298
Date Filed
June 17, 2019
Patent primary examiner
Find more entities like US Patent 10980784 Rapamycin analogs and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.